Tech Company Financing Transactions
EndoStim Funding Round
On 5/12/2016, EndoStim raised $25 million in Series D funding from Endeavour Vision, GIMV and Sante Ventures.
Transaction Overview
Company Name
Announced On
5/12/2016
Transaction Type
Venture Equity
Venture Equity
Venture Equity
Amount
$25,000,000
Round
Series D
Investors
Endeavour Vision (Lead Investor) (Alexander Schmitz)
Sante Ventures (Douglas French)
Proceeds Purpose
The Series D financing will support expanded commercialization efforts for EndoStim's minimally-invasive GERD therapy outside the United States; a randomized sham-controlled pivotal trial in the United States; and the development of next generation devices.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
4101 McEwen 336
Dallas, TX 75244
USA
Dallas, TX 75244
USA
Phone
Website
Email Address
Overview
EndoStim is a medical device company developing therapeutics for gastrointestinal and urological neuro-muscular disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Goode
Chief Financial Officer
Kim Pinson
Chief Medical Officer
Virender Sharma
Browse more venture capital transactions:
Prev: 5/12/2016: ExThera Medical venture capital transaction
Next: 5/12/2016: AcuFocus venture capital transaction
Share this article
About Database of VC Transactions
We document every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs